Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126840 · ClinicalTrials.gov registry record
Survivorship in Lynch Syndrome Families
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 303
- Enrollment target
NCT01126840: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01126840 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 303 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01126840 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 303 participants
- Enrollment target
Study Summary
Objectives: Specific Aims: 1. Researchers will evaluate and compare predictors of health-related quality of life (QOL) among colorectal cancer (CRC) survivors who have Lynch syndrome (LS) with those patients who have sporadic CRC using both quantitative and qualitative methodology. a. In both CRC groups, researchers will evaluate cancer preventive and health behaviors, including lifestyle factors and screening, psychosocial factors, including mood, family functioning, coping style, anxiety, depression, and social resources, and health care system factors, including interactions with health care providers and service utilization. 2. Researchers will compare the experience of first-degree relatives (FDRs) of patients who have LS with that of FDRs of patients who have sporadic CRC using both quantitative and qualitative methodology. a. Researchers will evaluate all of the domains listed above, as well as anticipatory grief, assessment of caregiving responsibilities, and fear of cancer in FDRs of patients with LS-related and sporadic CRC. 3. Researchers will examine CRC patients from both groups and their FDRs using dyadic analyses in order to evaluate the similarities and differences in their survivorship experience. 4. Researchers will evaluate the preventive and health behavior of patients who are non-conclusive for Lynch syndrome and their family members. They will examine their screening behavior and will explore how the interaction between the patients and their relatives affects the relatives' screening behavior. They also will examine how these non conclusive LS patients and their family members perceive their risk for LS-related cancers.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Telephone Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2010-06-20 |
| Est. Completion | 2022-09-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01126840
The ClinicalTrials.gov registry entry for NCT01126840 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT01126840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01126840 about?
NCT01126840 is a clinical study titled "Survivorship in Lynch Syndrome Families". Objectives: Specific Aims: 1. Researchers will evaluate and compare predictors of health-related quality of life (QOL) among colorectal cancer (CRC) survivors who have Lynch syndrome (LS) with those patients who have sporadic CRC using both quantitative and qualitative methodology. a. In both ...
What is the current status of trial NCT01126840?
This trial is currently completed. The enrollment target is 303 participants. The study started on 2010-06-20. Estimated completion is 2022-09-19.
What interventions are being tested in trial NCT01126840?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Telephone Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT01126840?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.